跳至主要内容
临床试验/NL-OMON54910
NL-OMON54910已完成不适用

Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia - RECOGNISED

Fundació Hospital Universitari Vall DHebron, VHIR0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
65 至 99(—)

入选标准

  • 1. Type 2 diabetes
  • 2. 65 years and older
  • 3. Diabetes duration of at least 5 years
  • 4. Mild to moderate non-proliferative diabetic retinopathy (NPDR) or with no
  • overt retinopathy
  • 5. Able to provide informed consent

排除标准

  • 1. Previous history of stroke or neurodegenerative diseases
  • 2. Severe NPDR, Proliferative DR (PDR), Diabetic Macular Edema (DME) or other
  • eye disorders affecting vision besides these complications of DR
  • 3. Previous laser photocoagulation
  • 4. Other diseases which may induce retinal neurodegeneration (e.g. glaucoma).
  • 5. Subjects with a refractive error = ± 6 D.
  • 6. Media opacities that preclude retinal imaging
  • 7. HbA1C > 10% (86 mmol/mol)
  • 8. Severe systemic illness or personal circumstances that would not make it
  • possible for the patients to fulfil study protocols

研究者

发起方
Fundació Hospital Universitari Vall DHebron, VHIR

相似试验